Cochrane Review Group

Schizophrenia

168 systematic reviews in Schizophrenia ask 2,589 questions. 23.2% have no studies to answer them, 27.8% rest on very low certainty evidence and 12.2% reach moderate or high certainty.

Reviews
168
Questions
2,589
current versions
No studies
23.2%
Moderate or high
12.2%
No studies 601 · 23.2%Ungraded 446 · 17.2%Very low 721 · 27.8%Low 505 · 19.5%Moderate 274 · 10.6%High 42 · 1.6%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Summary of findings table ‐ Collaborative care vs usual care
Quality of life: average change in mental health component (proxy for binary quality of life) · severe mental illness
Collaborative care approaches for people with severe mental illness (2024) · Cochrane
no estimate extracted3 studies · 227 participantsVery low
Summary of findings table ‐ Collaborative care vs usual care
Quality of life: average change in physical health component (proxy for physical health) · severe mental illness
Collaborative care approaches for people with severe mental illness (2024) · Cochrane
no estimate extracted3 studies · 237 participantsVery low
Summary of findings table ‐ Collaborative care vs usual care
Personal recovery ‐ not reported · severe mental illness
Collaborative care approaches for people with severe mental illness (2024) · Cochrane
no estimate extractedNRNo studies
Summary of findings table ‐ Collaborative care vs usual care
Experience of care/satisfaction ‐ not reported · severe mental illness
Collaborative care approaches for people with severe mental illness (2024) · Cochrane
no estimate extractedNRNo studies
Structured risk assessment vs standard professional care
Adverse effects (escape) · aggressive behaviour in schizophrenia
Risk assessment for aggressive behaviour in schizophrenia (2024) · Cochrane
RR 0.2 [0.01, 4.11]1 study · 200 participantsVery low
Structured risk assessment vs standard professional care
Adverse effects (fall down) · aggressive behaviour in schizophrenia
Risk assessment for aggressive behaviour in schizophrenia (2024) · Cochrane
RR 0.33 [0.04, 3.15]1 study · 200 participantsVery low
Structured risk assessment vs standard professional care
Adverse effects (choking) · aggressive behaviour in schizophrenia
Risk assessment for aggressive behaviour in schizophrenia (2024) · Cochrane
RR 0.2 [0.01, 4.11]1 study · 200 participantsVery low
Summary of findings table ‐ Cognitive behavioural therapy plus standard care vs control
Adverse events ‐ participants with at least one adverse event ‐ < 12 months · first‐episode or recent‐onset psychosis
Cognitive behavioural therapy added to standard care for first‐episode and recent‐onset psychosis (2024) · Cochrane
RR 1.29 [0.85, 1.97]1 study · 43 participantsVery low
Summary of findings table ‐ CBT without antipsychotics vs antipsychotics
Adverse events ‐ Participants with at least one AE (separated time points) ‐ < 12 months · schizophrenia
Cognitive behavioural therapy without medication for schizophrenia (2024) · Cochrane
RR 0.47 [0.21, 1.07]1 study · 40 participantsVery low
Summary of findings table ‐ CBT without antipsychotics vs CBT plus antipsychotics
Mental state ‐ general: mean endpoint overall symptoms scales (PANSS/BPRS) (high = poor) (separated time points) ‐ < 12 months · schizophrenia
Cognitive behavioural therapy without medication for schizophrenia (2024) · Cochrane
no estimate extracted3 studies · 125 participantsVery low
Summary of findings table ‐ CBT without antipsychotics vs CBT plus antipsychotics
Global state ‐ number of participants with relapse/exacerbations of psychosis (separated time points) ‐ < 12 months · schizophrenia
Cognitive behavioural therapy without medication for schizophrenia (2024) · Cochrane
RR 2.89 [0.12, 67.75]1 study · 90 participantsVery low
Summary of findings table ‐ CBT without antipsychotics vs CBT plus antipsychotics
Leaving the study early ‐ for any reason ‐ overall acceptability (separated time points) ‐ < 12 months · schizophrenia
Cognitive behavioural therapy without medication for schizophrenia (2024) · Cochrane
RR 0.7 [0.12, 4.11]2 studies · 90 participantsVery low

Reviews 168

Information and communication technology based prompting for treatment compliance for people with serious mental illness

Kauppi, K, Välimäki, M, et al. · Cochrane Database of Systematic Reviews · 2014
CochraneSoF table
7 questions

Trifluoperazine versus placebo for schizophrenia

Koch, K, Mansi, K, et al. · Cochrane Database of Systematic Reviews · 2014
CochraneSoF table
7 questions

User‐held personalised information for routine care of people with severe mental illness

Farrelly, S, Brown, GE, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
6 questions

Pimozide for schizophrenia or related psychoses

Mothi, M, Sampson, S · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
32 questions

Haloperidol dose for the acute phase of schizophrenia

Donnelly, L, Rathbone, J, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
7 questions

Haloperidol versus placebo for schizophrenia

Adams, CE, Bergman, H, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
7 questions

Training to recognise the early signs of recurrence in schizophrenia

Morriss, R, Vinjamuri, I, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
7 questions

Intermittent drug techniques for schizophrenia

Sampson, S, Mansour, M, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
42 questions

Quetiapine versus other atypical antipsychotics for schizophrenia

Asmal, L, Flegar, SJ, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
42 questions

Dance therapy for schizophrenia

Ren, J, Xia, J · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
7 questions

Quetiapine versus typical antipsychotic medications for schizophrenia

Suttajit, S, Srisurapanont, M, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
7 questions

Supported employment for adults with severe mental illness

Kinoshita, Y, Furukawa, TA, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
6 questions

Atypical antipsychotics for psychosis in adolescents

Kumar, A, Datta, SS, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
19 questions

Nidotherapy for people with schizophrenia

Chamberlain, IJ, Sampson, S · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
7 questions

Preventive interventions for postnatal psychosis

Essali, A, Alabed, S, et al. · Cochrane Database of Systematic Reviews · 2013
CochraneSoF table
5 questions

Life skills programmes for chronic mental illnesses

Tungpunkom, P, Maayan, N, et al. · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
10 questions

Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses

Jayakody, K, Gibson, RC, et al. · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
11 questions

Bromperidol decanoate (depot) for schizophrenia

Purgato, M, Adams, CE · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
13 questions

Management of sexual dysfunction due to antipsychotic drug therapy

Schmidt, HM, Hagen, M, et al. · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
27 questions

Benzodiazepines for schizophrenia

Dold, M, Li, C, et al. · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
17 questions

Information and communication technology in patient education and support for people with schizophrenia

Välimäki, M, Hätönen, H, et al. · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
14 questions

Acetylcholinesterase inhibitors for schizophrenia

Singh, J, Kour, K, et al. · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
7 questions

Paliperidone palmitate for schizophrenia

Nussbaum, AM, Stroup, TS · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
14 questions

Flupenthixol versus placebo for schizophrenia

Shen, X, Xia, J, et al. · Cochrane Database of Systematic Reviews · 2012
CochraneSoF table
7 questions

Psychoeducation for schizophrenia

Xia, J, Merinder, LB, et al. · Cochrane Database of Systematic Reviews · 2011
CochraneSoF table
7 questions